ArticleFrontiers in medicine2026
The association between triglyceride-glucose index with gestational diabetes mellitus in pregnant women: a cohort study among Chinese women.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the association between the triglyceride and glucose (TyG) index and gestational diabetes mellitus (GDM) in pregnant women to prevent GDM. Methods: A total of 1,222 first-trimester pregnant women from the Obstetrics Department of Peking University International Hospital were enrolled in this prospective study between December 2017 and March 2019. The patients underwent an oral glucose tolerance test at 24-28 weeks of gestation and were regularly followed up until birth. Results: The TyG index was significantly higher in the GDM group than in the non-GDM group ( Conclusion: The TyG index serves as an independent risk factor for GDM and may predict the disease in pregnant women. Although the TyG index can be used as a marker of gestational diabetes, we should also pay more attention to fasting blood glucose and HbA1c levels. The TyG index may be integrated into early screening programs for GDM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.